Volume 24, Number 4—April 2018
Research
Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010–2016
Figure 1
![Clonal complex and serogroup distribution of invasive meningococcal disease isolates, United Kingdom, 2010–2016. A) Proportional contribution of each cc of disease-causing culture-confirmed meningococcal isolates by epidemiologic year. Other cc indicates ccs that were found in <20 isolates during the 6-year study period. B) Distribution of isolate serogroups by epidemiologic year. Serogroups shown had >10 isolates during the 6-year study period. Serogroups with <10 isolates (A, E, X, an](/eid/images/17-1480-F1.jpg)
Figure 1. Clonal complex and serogroup distribution of invasive meningococcal disease isolates, United Kingdom, 2010–2016. A) Proportional contribution of each cc of disease-causing culture-confirmed meningococcal isolates by epidemiologic year. Other cc indicates ccs that were found in <20 isolates during the 6-year study period. B) Distribution of isolate serogroups by epidemiologic year. Serogroups shown had >10 isolates during the 6-year study period. Serogroups with <10 isolates (A, E, X, and Z) are shown in Table 1. CC, clonal complex; NG, nongroupable, W/Y, serogroups combined because of inconclusive serogrouping results.
Page created: March 19, 2018
Page updated: March 19, 2018
Page reviewed: March 19, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.